American Pharmacy News
  • State Issues
  • Regulatory
  • Federal Issues
  • Industry
  • Innovation
  • Directory
  • State Issues
  • Regulatory
  • Federal Issues
  • Industry
  • Innovation
  • Directory
  • Home
  • »
  • Stories
  • »
  • 2020
  • »
  • April

NOVARTIS: New analysis further showed durable and potent LDL-C reduction with inclisiran, an investigational first-in-class siRNA cholesterol-lowering treatment

American Pharmacy News Reports | Apr 1, 2020

Prespecified analysis of pooled data from ORION-9, -10 and -11 Phase III clinical trials showed inclisiran reduced low-density lipoprotein-cholesterol (LDL-C) by 51% at 17 months Read More »

APHA: Warns Pharmacists and Patients About COVID-19 Test and Product Scams

American Pharmacy News Reports | Apr 7, 2020

The American Pharmacists Association (APhA) cautions pharmacists and the public to be wary of fraudulent COVID-19 products and scams being offered online or through other channels during the pandemic. Read More »

CUMBERLAND PHARMACEUTICALS: To Help Prepare for the COVID-19 Patient Surge Cumberland Pharmaceuticals Expands Availability of Vaprisol® to Treat Hyponatremia in Critical Care Units

American Pharmacy News Reports | Apr 8, 2020

Vaprisol® safely and effectively addresses hyponatremia in the first 24 hours Read More »

EUROFINS DISCOVERY: Supports Critical COVID-19 Drug Discovery Research with Products and Accelerated Drug Discovery Services

American Pharmacy News Reports | Apr 14, 2020

Eurofins Discovery's mission is to support Pharmaceutical and Biotech companies in their efforts to accelerate drug discovery research and development. Read More »

SPARTA RX: Optio Rx Pharmacies Authorized by HHS to Conduct Rapid Test for COVID-19 Antibodies

American Pharmacy News Reports | Apr 17, 2020

Companies Across the Nation Can Take the First Step on the Path to Economic Recovery Read More »

5G Action Now launches geotargeted campaign on 5G's importance in telemedicine

April Bamburg | Apr 18, 2020
Telemedicine

In a digital ad campaign, the advocacy group 5G Action Now highlights five facts about 5G technology's vital role in the U.S. healthcare system and the fight against COVID-19. Read More »

NICHE PHARMACEUTICALS: Recommends Use of Its Mag-Tab®SR to Help Offset Cardiac Issues

American Pharmacy News Reports | Apr 23, 2020

Adding Magnesium To Hydroxychloroquine, Azithromycin and Zinc Treatment Protocols May Offset Cardiac Issues(1,3) Read More »

ORSINI HEALTHCARE: Orsini Pharmaceutical Services Selected To Provide VYEPTI™ (eptinezumab-jjmr) - The First And Only Intravenous Preventive Treatment For Migraine

American Pharmacy News Reports | Apr 23, 2020

Orsini Pharmaceutical Services is a select dispensing pharmacy for the first FDA-approved, infused migraine preventive therapy by pharmaceutical manufacturer H. Lundbeck A/S based in Denmark Read More »

CVS HEALTH: To Significantly Expand COVID-19 Testing Capabilities

American Pharmacy News Reports | Apr 29, 2020

Next phase will utilize company presence in communities across the country Read More »

UWORLD: Acquires RxPrep to Offer Online Learning for Aspiring Pharmacists

American Pharmacy News Reports | Apr 30, 2020

UWorld will continue RxPrep’s mission to prepare pharmacy students to succeed on their exams with premium content, intuitive technology, and a superior customer experience. Read More »

Trending

Diana Harshbarger, U.S. Representative for Tennessee's 1st District

Rep. Harshbarger calls for PBM transparency, oversight: 'It’s time to shine a light on their shady practices'

Sally Pipes, President & CEO of Pacific Research Institute

Pacific Research Institute CEO Pipes on 340B program: It 'has become a major revenue stream for large hospital systems'

Elise Shutzer, Vice President of Public Affairs at PhRMA

PhRMA launches 'Goldmine: Spa Day' campaign targeting 340B hospital drug pricing program

Ted Okon, MBA, Executive Director, Community Oncology Alliance

Community Oncology Alliance Executive Director Okon on 340B: ‘Expanding participation in a flawed program isn’t reform’

Paul Gigot, Editor-in-chief, Wall Street Journal

WSJ Editorial Board says 340B program has been exploited following North Dakota ruling

Copyright © 2026 American Pharmacy News. All Rights Reserved.

  • About
  • Contact
  • Privacy Policy
  • Terms of Service

Alerts Sign-up